SCHEMBL24028641

SCHEMBL24028641

N#Cc1ccc2c(c1)c1ccccc1n2-c1ccccc1-c1cc(-n2c3ccccc3c3ccccc32)nc(-c2cccc(C(c3ccccc3)(c3ccccc3)c3ccccc3)c2)n1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 12/20 0.34
▸ CYP3A4 P08684 11/20 0.34
▸ CYP2D6 P10635 8/20 0.34
▸ CLK4 Q9HAZ1 8/20 0.34
▸ MEN1 O00255 7/20 0.34
▸ KMT2A Q03164 7/20 0.34
▸ LMNA P02545 6/20 0.34
▸ ALDH1A1 P00352 6/20 0.34
▸ HSD17B10 Q99714 5/20 0.34
▸ CYP2C19 P33261 5/20 0.34
▸ MAPK1 P28482 5/20 0.34
▸ TSHR P16473 5/20 0.34
▸ CYP2C9 P11712 4/20 0.34
▸ USP2 O75604 7/20 0.34
▸ ALOX15 P16050 1/20 0.34
▸ HIF1A Q16665 1/20 0.34
▸ TP53 P04637 2/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ CNR2 P34972 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24028522 0.93 PTGER4 (0.33) CYP1A2CYP3A4CYP2D6CLK4MEN1
SCHEMBL24028636 0.90 CYP1A2 (0.41) CYP1A2CYP3A4CYP2D6CLK4MEN1
SCHEMBL24028693 0.90 TSHR (0.33) LMNAALDH1A1HSD17B10MAPK1TSHR
SCHEMBL24028294 0.87 CYP1A2 (0.35) CYP1A2CYP3A4CYP2D6CLK4MEN1
SCHEMBL24028642 0.86 CYP1A2 (0.35) CYP1A2CYP3A4CYP2D6CLK4MEN1
SCHEMBL24029180 0.85 CYP1A2 (0.43) CYP1A2CYP3A4CYP2D6CLK4MEN1
SCHEMBL24029082 0.85 ABCG2 (0.42) CYP1A2CYP3A4CYP2D6CLK4MEN1
SCHEMBL24028695 0.84 ACP1 (0.36) CYP1A2CYP3A4CYP2D6CLK4MEN1
SCHEMBL24029028 0.83 CYP1A2 (0.40) CYP1A2CYP3A4CYP2D6CLK4MEN1
SCHEMBL24028876 0.82 PTGER4 (0.37) CYP1A2CYP3A4CYP2D6CLK4MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210359215-A1 COMPOUND AND LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2021-11-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210359215-A1 COMPOUND AND LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, SIRT1 CYP1A2 250/4885CYP3A4 525/4885CYP2D6 1169/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback